Close
Close
Treatment Database
human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment (ready to use pre-filled syringe)
Trade Name not avaiable
Orphan Indication Short bowel syndrome
USA Market Approval
USA Designation Date 01-05-2019
Sponsor Hanmi Pharmaceutical Co. Ltd.
14, Wiryeseong-daero
Songpa-gu
More about Short bowel syndrome
Free Newsletter
Related Videos
by Abidemi Uruejoma
9,467 views